간단한 2D 및 3D 세포 배양이 가능하도록 설계된 혁신적인 3D 프린팅 인서트

Executive Industry Relevance

Efficient modeling of direct and indirect cell communication is critical for early discovery and target validation in biopharma R&D. The 3D-printed insert system enables multiplexed co-culture of up to four cell types in both 2D and 3D formats, supporting physiologically relevant assays and accelerating hypothesis-driven research. This flexible platform enhances predictive confidence and streamlines the transition from discovery biology to preclinical model development.

Strategic Applications in Biopharma R&D

Early Discovery & Target Validation

• Enables interrogation of paracrine and direct cell-cell interactions in a controlled, multi-compartment format.
• Supports functional target validation by allowing simultaneous analysis of multiple cell types and conditions.
• Facilitates mechanistic de-risking by modeling physiopathological communication pathways.
• Improves predictive confidence for downstream portfolio triage decisions.

Screening & Assay Development

• Prepares validated co-culture systems for quantitative proliferation and migration assays.
• Standardizes assay conditions across compartments, enhancing reproducibility and scalability.
• Enables parallel testing of reagents or conditions for robust compound evaluation.
• Supports platform reuse for diverse cell types and assay formats.

Translational & Preclinical Research

• Aligns in vitro models with disease-relevant intercellular communication for translational biomarker studies.
• Maintains continuity from early discovery through preclinical validation by enabling physiologically relevant co-culture conditions.
• Reduces risk of late-stage biological failure by providing more predictive in vitro data.

Pipeline & Workflow Integration

The 3D-printed insert system bridges early discovery, screening, and translational research by enabling multiplexed, physiologically relevant co-culture assays within standard plate formats.

• Discovery Biology: Supports hypothesis testing of cell-cell communication and pathway modulation.
• Screening: Delivers reproducible, quantitative outputs for proliferation and migration endpoints.
• Analytics: Facilitates independent collection and analysis of RNA, protein, and viability data from each compartment.
• Translational Research: Models disease-relevant interactions for biomarker alignment and preclinical continuity.
• Enterprise Reuse: Provides a durable, sterilizable platform adaptable to various cell types and experimental designs.

Operational & Enterprise Impact

• Scientific Value: Increases predictive confidence and reduces mechanistic ambiguity in cell communication studies.
• Operational Value: Enhances standardization, reproducibility, and scalability across R&D teams.
• Strategic Value: Improves go/no-go decision quality and capital efficiency by enabling robust early-stage data.
• Portfolio Impact: Supports risk-adjusted prioritization and advancement of discovery programs.

Implementation Considerations

• Requires expertise in cell culture and co-culture assay design.
• Needs access to standard cell culture instrumentation and analytical tools for viability and molecular analysis.
• Demands rigorous sealing and sterilization protocols to prevent cross-contamination between compartments.
• Adaptable to a range of adherent cell types and compatible with both 2D and 3D culture formats.
• Practical limitations include careful handling to maintain compartment integrity and prevent medium leakage.

Biopharma FAQs